Akso Health Group(AHG)Earnings, Financials & Key Ratios
AHG•NASDAQ•Banking & Credit
$2.05
$584M mkt cap·Price updated May 7, 2026
SectorFinancial ServicesIndustryCredit ServicesSub-IndustryConsumer Credit Issuers and Installment Lenders
AboutAkso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.Show more
- Net Interest Income$0
- Total Revenue$15M+512.1%
- Net Income-$135M-1327.0%
- Return on Equity-79.97%-522.5%
- Net Interest Margin0%
- Efficiency Ratio1123.46%+209.6%
- ROA-75.62%-549.5%
- Equity / Assets92.65%-4.9%
- Book Value per Share0.70-88.0%
- Tangible BV/Share0.63-89.1%
- Debt/Equity0.00
AHG Key Insights
Akso Health Group (AHG) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Momentum leader: RS Rating 87 (top 13%)
- ✓Well capitalized: 92.6% equity/assets
- ✓Diversified revenue: 100.0% from non-interest income
✗Weaknesses
- ✗High cost structure: 1123.5% efficiency ratio
- ✗Shares diluted 100.0% in last year
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
AHG Price & Volume
Akso Health Group (AHG) stock price & volume — 10-year historical chart
Loading chart...
AHG Growth Metrics
Akso Health Group (AHG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years12.27%
5 Years16.4%
3 Years35.05%
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-1389.46%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM38.21%
Return on Capital
10 Years-18.69%
5 Years-66.08%
3 Years-81.58%
Last Year-97.95%
AHG Recent Earnings
Akso Health Group (AHG) EPS & revenue vs analyst estimates — last 4 quarters
●Beat Revenue 0/12 qtrs (0%)
Q2 2025Latest
Mar 28, 2025EPS
$0.00
Revenue
$3M
Q3 2024
Jul 30, 2024EPS
$0.04
Revenue
$760,377
Q3 2024
Jul 12, 2024EPS
$0.00
Revenue
$3M
Q1 2024
Jan 12, 2024EPS
$0.07
Revenue
$446,792
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2025Latest | Mar 28, 2025 | $0.00 | $3M |
| Q3 2024 | Jul 30, 2024 | $0.04 | $760,377 |
| Q3 2024 | Jul 12, 2024 | $0.00 | $3M |
| Q1 2024 | Jan 12, 2024 | $0.07 | $446,792 |
Based on last 12 quarters of dataView full earnings history →
AHG Peer Comparison
Akso Health Group (AHG) competitors in Consumer Credit Issuers and Installment Lenders — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 JFIN | 533.52M | 4.94 | 1.69 | 6.11% | 26.17% | 39.74% | 0.02 | |
 QFIN | 3.75B | 13.21 | 2.15 | 5.38% | 28.76% | 0.07 | ||
 LX | 146.96M | 2.06 | 2.16 | 8.78% | 14.68% | 0.49 | ||
 FINV | 2.9B | 5.12 | 3.85 | 3.69% | 17.43% | 0.00 | ||
 HCM | 2.29B | 13.31 | 60.50 | -24.8% | 77.53% | 46.37% | 0.12 | |
 BTBT | 589.49M | 1.83 | 9.15 | 264.59% | 21.41% | 0.03 | ||
 NHTC | 35.71M | 3.20 | -41.72 | -7.42% | -3.03% | -4.88% | 0.13 | |
 CLOV | 1.44B | 2.82 | -16.59 | 40.34% | -2.58% | -17.08% |
Compare AHG vs Peers
Akso Health Group (AHG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AHG Income Statement
Akso Health Group (AHG) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|
| Net Interest Income | 0 | 590.12K | 0 | -2.5M | -2.15M | -804.14K | 0 | 0 | 0 |
| NII Growth % | - | - | -100% | - | 13.77% | 62.68% | 100% | - | - |
| Net Interest Margin % | 0% | 0.36% | 0% | -3.1% | -6.8% | -1.28% | 0% | 0% | 0% |
| Interest Income | 0 | 590.12K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 2.5M | 2.15M | 804.14K | 0 | 0 | 0 |
| Loan Loss Provision | 5.15M | 8.5M | 0 | -2.5M | -1.61M | 4.59M | 11.91M | 2.29M | 15.06M |
| Non-Interest Income | 22.92M | 106.67M | 3.7M | 6.91M | 1.75M | 6M | 13.18M | 2.41M | 14.78M |
| Non-Interest Income % | 100% | 99.45% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Total Revenue | 22.92M▲ 0% | 107.26M▲ 368.0% | 3.7M▼ 96.6% | 6.91M▲ 87.1% | 1.75M▼ 74.6% | 6M▲ 241.9% | 13.18M▲ 119.7% | 2.41M▼ 81.7% | 14.78M▲ 512.1% |
| Revenue Growth % | 92.7% | 367.96% | -96.55% | 87.12% | -74.62% | 241.89% | 119.69% | -81.68% | 512.08% |
| Non-Interest Expense | 7.86M | 22.89M | 10.88M | 55.02M | 28.36M | 3.87M | 15.54M | 8.76M | 166.02M |
| Efficiency Ratio | 34.28% | 21.34% | 294.55% | 795.72% | 1616.02% | 64.43% | 117.86% | 362.84% | 1123.46% |
| Operating Income | 9.91M▲ 0% | 75.88M▲ 665.4% | -7.19M▼ 109.5% | -48.11M▼ 569.1% | -27.15M▲ 43.6% | -3.26M▲ 88.0% | -14.27M▼ 337.6% | -8.64M▲ 39.5% | -166.3M▼ 1825.3% |
| Operating Margin % | 43.25% | 70.74% | -194.55% | -695.72% | -1547.05% | -54.34% | -108.23% | -357.78% | -1125.37% |
| Operating Income Growth % | 139.44% | 665.37% | -109.47% | -569.14% | 43.56% | 87.99% | -337.57% | 39.45% | -1825.26% |
| Pretax Income | 10.09M▲ 0% | 76.54M▲ 658.3% | -6.81M▼ 108.9% | -46.87M▼ 588.5% | -3.81M▲ 91.9% | -4.01M▼ 5.2% | -13.07M▼ 226.0% | -9.09M▲ 30.4% | -166.27M▼ 1728.8% |
| Pretax Margin % | 44.04% | 71.36% | -184.24% | -677.9% | -217.12% | -66.8% | -99.13% | -376.57% | -1125.14% |
| Income Tax | 1.52M | 11.03M | 807.71K | 489.95K | 482.98K | 92.82K | 17.55K | 24.99K | -30.8M |
| Effective Tax Rate % | 15.08% | 14.41% | -11.86% | -1.05% | -12.68% | -2.32% | -0.13% | -0.27% | 18.52% |
| Net Income | 8.57M▲ 0% | 65.48M▲ 664.0% | 5.53M▼ 91.6% | -71.2M▼ 1386.9% | -34.83M▲ 51.1% | -16.85M▲ 51.6% | -1.36M▲ 91.9% | -9.46M▼ 595.5% | -134.98M▼ 1327.0% |
| Net Margin % | 37.39% | 61.05% | 149.72% | -1029.7% | -1984.52% | -280.83% | -10.32% | -391.78% | -913.38% |
| Net Income Growth % | 142.22% | 664.01% | -91.55% | -1386.89% | 51.08% | 51.62% | 91.93% | -595.54% | -1327.01% |
| Net Income (Continuing) | 8.57M | 65.51M | -7.62M | -47.36M | -4.29M | -4.1M | -13.08M | -9.12M | -135.47M |
| EPS (Diluted) | 1.62▲ 0% | 12.36▲ 663.0% | 0.93▼ 92.5% | -13.14▼ 1512.9% | -0.27▲ 97.9% | -2.55▼ 844.4% | -0.06▲ 97.6% | -0.39▼ 550.0% | -0.48▼ 23.1% |
| EPS Growth % | 145.45% | 662.96% | -92.48% | -1512.9% | 97.95% | -844.44% | 97.65% | -550% | -23.08% |
| EPS (Basic) | 1.62 | 12.36 | 0.93 | -13.14 | -0.26 | -2.55 | -0.06 | -0.45 | -0.48 |
| Diluted Shares Outstanding | 5.32M | 5.3M | 5.88M | 5.42M | 5.43M | 6.62M | 7.62M | 23.83M | 285.1M |
AHG Balance Sheet
Akso Health Group (AHG) balance sheet — assets, liabilities & shareholders' equity
| Line item | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 19.23M | 132.62M | 57.37M | 6.67M | 15.13M | 18.43M | 7.92M | 85.17M | 176.23M |
| Cash & Due from Banks | 19.23M | 132.62M | 57.37M | 6.67M | 15.13M | 18.43M | 7.92M | 85.17M | 176.23M |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Investments | 0 | 0 | 30.79M | 1.6M | 0 | 0 | 0 | 0 | 0 |
| Investments Growth % | - | - | - | -94.8% | -100% | - | - | - | - |
| Long-Term Investments | 0 | 0 | 30.79M | 1.6M | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivables | 0 | 0 | 140.64K | -546.04K | 28.36K | 0 | 7.7M | 0 | 954.2K |
| Goodwill & Intangibles | 0 | 331.58K | 0 | 0 | 0 | 0 | 0 | 0 | 18.71M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.83M |
| Intangible Assets | 0 | 331.58K | 0 | 0 | 0 | 0 | 0 | 0 | 7.88M |
| PP&E (Net) | 427.94K | 767.09K | 1.25M | 763.57K | 66.89K | 55.43K | 0 | 0 | 114.54K |
| Other Assets | 0 | -331.58K | 39.81M | 26.09M | 1.5M | 121.54K | 0 | 0 | 0 |
| Total Current Assets | 27.55M | 163.12M | 97.68M | 52.02M | 30.12M | 62.63M | 20.46M | 142.02M | 196.12M |
| Total Non-Current Assets | 828K | 767.09K | 75.58M | 28.46M | 1.56M | 176.98K | 0 | 0 | 18.83M |
| Total Assets | 28.38M▲ 0% | 163.89M▲ 477.4% | 173.26M▲ 5.7% | 80.48M▼ 53.6% | 31.69M▼ 60.6% | 62.81M▲ 98.2% | 20.46M▼ 67.4% | 142.02M▲ 594.1% | 214.95M▲ 51.4% |
| Asset Growth % | 26.75% | 477.44% | 5.71% | -53.55% | -60.63% | 98.22% | -67.42% | 594.12% | 51.36% |
| Return on Assets (ROA) | 33.76% | 68.11% | 3.28% | -56.12% | -62.1% | -35.66% | -3.27% | -11.64% | -75.62% |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt | 0 | 0 | 20M | 20.75M | 10M | 0 | 0 | 0 | 81.74K |
| Net Debt | -19.23M | -132.62M | -37.37M | 14.09M | -5.13M | -18.43M | -7.92M | -85.17M | -176.15M |
| Long-Term Debt | 0 | 0 | 20M | 20M | 0 | 0 | 0 | 0 | 0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 10M | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | -96.23K | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 4.88M | 23.85M | 26.56M | 12.36M | 14.41M | 50.52M | 11.62M | 3.59M | 13.81M |
| Total Non-Current Liabilities | 0 | 3.79B | 20.19M | 20.01M | 0 | 0 | 0 | 0 | 1.99M |
| Total Liabilities | 4.88M | 23.85M | 46.75M | 32.38M | 14.41M | 50.52M | 11.62M | 3.59M | 15.8M |
| Total Equity | 23.5M▲ 0% | 140.04M▲ 495.8% | 126.5M▼ 9.7% | 48.1M▼ 62.0% | 17.27M▼ 64.1% | 12.29M▼ 28.9% | 8.84M▼ 28.0% | 138.42M▲ 1466.0% | 199.15M▲ 43.9% |
| Equity Growth % | 67.75% | 495.82% | -9.67% | -61.98% | -64.09% | -28.87% | -28.05% | 1465.97% | 43.87% |
| Equity / Assets (Capital Ratio) | 82.81% | 85.45% | 73.02% | 59.77% | 54.51% | 19.56% | 43.2% | 97.47% | 92.65% |
| Return on Equity (ROE) | 45.69% | 80.08% | 4.15% | -81.55% | -106.55% | -114.01% | -12.88% | -12.85% | -79.97% |
| Book Value per Share | 4.41 | 26.45 | 21.52 | 8.88 | 3.18 | 1.85 | 1.16 | 5.81 | 0.70 |
| Tangible BV per Share | 4.41 | 26.38 | 21.52 | 8.88 | 3.18 | 1.85 | 1.16 | 5.81 | 0.63 |
| Common Stock | 4.29K | 4.8K | 4.96K | 5K | 5K | 6.98K | 6.98K | 43.83K | 165.68K |
| Additional Paid-in Capital | 13.29M | 58.42M | 59.81M | 60.56M | 60.62M | 71.02M | 71.02M | 210.32M | 405.62M |
| Retained Earnings | 11.76M | 77.24M | 69.77M | -1.43M | -36.26M | -53.11M | -54.47M | -63.93M | -198.9M |
| Accumulated OCI | -1.54M | 4.38M | -1.76M | -7.05M | -3.1M | -1.65M | -3.85M | -4.09M | -3.77M |
| Treasury Stock | 0 | 0 | -1.32M | -3.99M | -3.99M | -3.99M | -3.99M | -3.99M | -3.99M |
| Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AHG Cash Flow Statement
Akso Health Group (AHG) cash flow — operating, investing & free cash flow history
| Line item | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 8.19M | 87.72M | -1.73M | -55.87M | 10.06M | -8.63M | -3.25M | 1.35M | 1.18M |
| Operating CF Growth % | 16.57% | 971.13% | -101.97% | -3127.23% | 118% | -185.78% | 62.29% | 141.53% | -12.88% |
| Net Income | 8.57M | 65.51M | 5.53M | -71.2M | -34.72M | -16.85M | -13.08M | -9.12M | -135.47M |
| Depreciation & Amortization | 92.22K | 174.38K | 406.8K | 580.5K | 15.16K | 18.39K | 0 | 0 | 2.15M |
| Deferred Taxes | 135.64K | 415.62K | -3.72B | 3.58B | 26.76M | 0 | 0 | 0 | -30.8M |
| Other Non-Cash Items | 320.09K | -525.91K | 3.73B | -3.54B | -3.16M | 10.38M | 11M | 8.41M | 162.28M |
| Working Capital Changes | -608.99K | 20.32M | -15.34M | -30.9M | 21.11M | -2.56M | -1.17M | 2.06M | 3.02M |
| Cash from Investing | -287.76K | -27.62M | -68.11M | 12.78M | -662 | -19.96M | 18.47M | -54.72M | -105.91M |
| Purchase of Investments | 0 | 0 | -16.5M | -14.59M | 0 | 0 | 0 | 0 | 0 |
| Sale/Maturity of Investments | 0 | 0 | -5.9K | -7.82K | 0 | 0 | 0 | 0 | 0 |
| Net Investment Activity | 0 | 0 | -16.51M | -14.6M | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 5.9K | 7.82K | 0 | 0 | 0 | 0 | -93.75M |
| Other Investing | 0 | -27.17M | -50.66M | 27.68M | -662 | -19.96M | 18.47M | -54.72M | -12.01M |
| Cash from Financing | 4.29M | 47.52M | -29.38K | -3.97M | -9.04M | 34.78M | -27.51M | 131.65M | 195.88M |
| Dividends Paid | 0 | 0 | -19.55M | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -1.32M | -2.67M | 0 | 0 | 0 | 0 | 0 |
| Stock Issued | 2M | 43.27M | 0 | 0 | 5 | 10.02M | 0 | 139.34M | 195.88M |
| Net Stock Activity | 2M | 43.27M | -1.32M | -2.67M | 5 | 10.02M | 0 | 139.34M | 195.88M |
| Debt Issuance (Net) | 0 | 0 | 1000K | 0 | -1000K | -1000K | -1000K | -1000K | 0 |
| Other Financing | 2.29M | 4.24M | 838.62K | -1.3M | 962.77K | 34.76M | 0 | 0 | 0 |
| Net Change in Cash | 11.41M▲ 0% | 113.39M▲ 893.5% | -75.25M▼ 166.4% | -46.45M▲ 38.3% | 4.2M▲ 109.1% | 6.8M▲ 61.7% | -12.73M▼ 287.3% | 77.01M▲ 704.8% | 90.03M▲ 16.9% |
| Exchange Rate Effect | -777.29K | 1000K | -1000K | 608.64K | 1000K | 607.72K | -436.51K | -1000K | -1000K |
| Cash at Beginning | 7.82M | 19.23M | 132.62M | 57.37M | 10.93M | 15.13M | 21.93M | 9.19M | 86.2M |
| Cash at End | 19.23M | 132.62M | 57.37M | 10.93M | 15.13M | 21.93M | 9.19M | 86.2M | 176.23M |
| Interest Paid | 0 | 0 | 0 | 2.41M | 0 | 676.89K | 336.59K | 111.56K | 0 |
| Income Taxes Paid | 300.6K | 1.02M | 12.25M | 3.21M | 0 | 92.82K | 17.55K | 24.99K | 2.98K |
| Free Cash Flow | 7.9M▲ 0% | 87.27M▲ 1004.4% | -2.68M▼ 103.1% | -56.18M▼ 1999.5% | 10.06M▲ 117.9% | -8.63M▼ 185.8% | -3.25M▲ 62.3% | 1.35M▲ 141.5% | 1.02M▼ 24.3% |
| FCF Growth % | 14.44% | 1004.37% | -103.07% | -1999.5% | 117.9% | -185.83% | 62.32% | 141.53% | -24.31% |
AHG Banking Ratios
Akso Health Group (AHG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 40.76% | 45.69% | 80.08% | 4.15% | -81.55% | -106.55% | -114.01% | -12.88% | -12.85% | -79.97% |
| Return on Assets (ROA) | 23.76% | 33.76% | 68.11% | 3.28% | -56.12% | -62.1% | -35.66% | -3.27% | -11.64% | -75.62% |
| Net Interest Margin | 0% | 0% | 0.36% | 0% | -3.1% | -6.8% | -1.28% | 0% | 0% | 0% |
| Efficiency Ratio | 45.36% | 34.28% | 21.34% | 294.55% | 795.72% | 1616.02% | 64.43% | 117.86% | 362.84% | 1123.46% |
| Equity / Assets | 62.57% | 82.81% | 85.45% | 73.02% | 59.77% | 54.51% | 19.56% | 43.2% | 97.47% | 92.65% |
| Book Value / Share | 2.63 | 4.41 | 26.45 | 21.52 | 8.88 | 3.18 | 1.85 | 1.16 | 5.81 | 0.7 |
| NII Growth | - | - | - | -100% | - | 13.77% | 62.68% | 100% | - | - |
| Dividend Payout | - | - | - | 353.32% | - | - | - | - | - | - |
AHG Frequently Asked Questions
Akso Health Group (AHG) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Akso Health Group (AHG) grew revenue by 512.1% over the past year. This is strong growth.
Akso Health Group (AHG) reported a net loss of $135.0M for fiscal year 2025.
Dividend & Returns
Akso Health Group (AHG) has a return on equity (ROE) of -80.0%. Negative ROE indicates the company is unprofitable.
Industry Metrics
Akso Health Group (AHG) has a net interest margin (NIM) of N/A. NIM has been under pressure due to interest rate environment.
Akso Health Group (AHG) has an efficiency ratio of 1123.5%. This is higher than peers, suggesting room for cost optimization.
Explore More AHG
Akso Health Group (AHG) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates